Women and HIV

HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.
Rutledge R, Madden L, Ogbuagu O, Meyer JP.
AIDS Care. 2018 Mar 11:1-8.
Abstract
A PrEP Information and Self-Screening Tool for Women
Collier KL, Colarossi LG, Sanders K.
AIDS Educ Prev. 2018 Feb;30(1):13-2
Abstract

A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective.
Bailey JL, Molino ST, Vega AD, Badowski M.
Infect Dis Ther. 2017 Jun 9.
Abstract

Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception.
Balkus JE, Palanee-Phillips T, Reddy K, et al
J Acquir Immune Defic Syndr. 2017 May
Abstract

Design and In vitro Evaluation of Tenofovir - Loaded Vaginal Gels for the Prevention of HIV Infections.
Timur SS, Şahin A, Aytekin E, Öztürk N, et al
Pharm Dev Technol. 2017 May 15:
Abstract

Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives
Collier KL, Colarossi LG, Sanders K.
J Health Commun. 2017 Mar;22(3):183-189.
Abstract

Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic.
Blackstock OJ, Patel VV, Felsen U, et al
AIDS Care. 2017 Feb 1:1-4.
Abstract

Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.
Wahl A, Ho PT, Denton PW, Garrett KL, et al
Sci Rep. 2017 Feb 1;7:41098.
Abstract

Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
Nel A, van Niekerk N, Kapiga S, et al
N Engl J Med. 2016 Dec;375(22):2133-2143.
Abstract

Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.
Hanscom B, Janes HE, Guarino PD,
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):606-608.
Abstract

HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
Lund JM, Broliden K, Pyra MN, Thomas KK, et al J Virol. 2016 Aug 24.
Abstract

Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.
Hanscom B, Janes HE, Guarino PD, et al
J Acquir Immune Defic Syndr. 2016 Aug 16
Abstract

HIV pre-exposure prophylaxis for women.
Sheth AN, Rolle CP, Gandhi M.
J Virus Erad. 2016 Jul 1;2(3):149-5
Abstract

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
Amico KR, Wallace M, Bekker LG, et al
AIDS Behav. 2016 Jun 17.
Abstract

The Potential of Pre-Exposure Prophylaxis for Women in Violent Relationships.
Braksmajer A, Senn TE, McMahon J.
AIDS Patient Care STDS. 2016 Jun;30(6):274-81
Abstract

Safety and pharmacokinetics of quick dissolving polymeric vaginal films delivering the antiretroviral IQP-0528 for pre-exposure prophylaxis.
Srinivasan P, Zhang J, Martin A, et al
Antimicrob Agents Chemother. 2016 May 2.
Abstract

FULL TEXT ARTICLE
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
Nel A, Bekker LG, Bukusi E, et al
PLoS One. 2016 Mar 10;11(3):e0147743
Paper

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
Baeten JM, Palanee-Phillips T, Brown ER, et al
N Engl J Med. 2016 Feb 22
Abstract

Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
Cowan FM, Delany-Moretlwe S.
Curr Opin HIV AIDS. 2016 Jan;11(1):27-34.
Abstract

When the science fails and the ethics works: 'Fail-safe' ethics in the FEM-PrEP study.
Kingori P.
Anthropol Med. 2015 Oct 20:1-17
Abstract

HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.
Doblecki-Lewis S, Lester L, et al
Int J STD AIDS. 2015 Sep 18.
Abstract

FULL-TEXT ARTICLE
Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
Celum CL, Delany-Moretlwe S, McConnell M, et al
J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):2022
Paper

Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
Corneli A, Namey E, Ahmed K, et al
AIDS Patient Care STDS. 2015 Jul 21.
Abstract

Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.
Hoffman RM, Jaycocks A, Vardavas R, et al
J Infect Dis. 2015 Jun 19. .
Abstract

The Science of Being a Study Participant: FEM-PrEP Participants' Explanations for Overreporting Adherence to the Study Pills and for the Whereabouts of Unused Pills.
Corneli AL, McKenna K, Perry B, et al
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):578-584.
Abstract

Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo JM, Ramjee G, Richardson BA, et al
N Engl J Med. 2015 Feb 5;372(6):509-18.
Abstract

Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R, Mugo N, Were E, et al
AIDS. 2014 Nov 28;28(18):2771-2776.
Abstract

A combination vaginal ring releasing dapivirine and darunavir.
Malcolm K, Murphy D, Desjardins D, et al
AIDS Res Hum Retroviruses. 2014 Oct;30 Suppl 1:A12-3.
Abstract

FULL-TEXT ARTICLE
The Sexual Risk Context among the FEM-PrEP Study Population in Bondo, Kenya and Pretoria, South Africa.
Headley J, Lemons A, Corneli A, et al
PLoS One. 2014 Sep 17;9(9):e106410.
Paper

Young Adult Women and Correlates of Potential Adoption of Pre-exposure Prophylaxis (PrEP): Results of a National Survey.
Rubtsova A, Wingood GM, Dunkle K,
Curr HIV Res. 2014 Jan 28
Abstract

MEDICAL ADVOCATES WOMEN AND HIV RESOURCE CENTER HIV Prevention
		Main Page
		General/Miscellaneous Studies Pregnancy Virology Immunology Post-exposure Prophylaxis Pre-exposure Prophylaxis Microbicides Note: National Prevention Studies are Indexed under Global/National Challenges

Conference Reports, Abstracts, and Posters

	Development of a new intravaginal ring technology for the extended delivery of the microbicide tenofovir with and without the contraceptive levonorgestrel T. Johnson, M. Clark, J. Clark, et al (XIX International AIDS Conference) Abstract Women Initiated Solution to Prevent HIV/AIDS (The WISH Study): factors associated with intentions to use microbicides and tenofovir S. Kandathil, S.M. Harvey, D. Champeau, et al (XIX International AIDS Conference) Abstract

Injectable Contraception